Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • ER stress in inflammatory bowel disease
  • Genomic analysis of pathogenic and benign gastritis bacteria
  • Witnessing clonal deletion in action
  • Version history
  • Article usage
  • Citations to this article (0)

Advertisement

In this issue Free access | 10.1172/JCI119921

In This Issue

John Ashkenas, Science Editor

Find articles by Ashkenas, J. in: JCI | PubMed | Google Scholar

Published March 1, 2001 - More info

Published in Volume 107, Issue 5 on March 1, 2001
J Clin Invest. 2001;107(5):531–531. https://doi.org/10.1172/JCI119921.
© 2001 The American Society for Clinical Investigation
Published March 1, 2001 - Version history
View PDF
ER stress in inflammatory bowel disease

(See article on pages 585– 593.)

Eukaryotic cells respond to the accumulation of unfolded proteins in the endoplasmic reticulum (ER) through a pathway termed the ER stress response. Although aspects of this pathway differ from yeast to mammals, the role of certain upstream effectors, including the Ire1 proteins, has been conserved, and the pathway in all cases induces the synthesis of protective ER chaperone proteins. The mouse Ire1α protein is ubiquitously expressed and is essential early in development, but Bertolotti and colleagues now show that the related protein Ire1β, which is found in the stomach and intestines, plays a more subtle role. Mice lacking this isoform develop normally, but, taking a cue from the restricted expression of Ire1beta;, the authors examined the mutant mice for a defect in the gastrointestinal tract. The gastric epithelium in Ire1beta;-/- animals appears normal but proves to be hypersensitive to the effects of dextran sodium sulfate, an irritant that induces the ER stress response and provokes inflammatory bowel disease in mice. Epithelial cells in mutant mice show higher base-line levels of the ER resident chaperone protein BiP and of activated MAP kinase, which acts both in the unfolded protein response in the ER and in similar cytoplasmic pathways - phenotypes that might be expected if the absence of Ire1beta; leaves the gastric mucosa unprotected in the presence of damaging levels of unfolded proteins in the secretory pathway. Evidently, Ire1α and other sensor proteins can activate unfolded protein responses to some extent, but in the absence of Ire1beta; they do not allow for normal cellular homeostasis in this tissue.

Genomic analysis of pathogenic and benign gastritis bacteria

(See article on pages 611–620.)

Infection with the mucosal resident bacterium Helicobacter pylori can lead to a series of diseases of the gut, culminating in some cases in gastric adenocarcinomas. Still, most long-term H. pylori carriers are apparently unharmed by the bacterium, perhaps because they are protected by some genetic or environmental factors or because only a subset of H. pylori strains are virulent. Work in a gerbil model of H. pylori infection argues for the latter possibility, and Israel et al. have now used whole genome analysis to examine the genetic differences between two strains, B128 and G1.1, that differ in their effects on host cells. When studied in live animals or in culture, B28 consistently induces higher levels of inflammatory cytokines and a greater degree of epithelial cell death than does G1.1. Both strains carry a large chromosomally inserted element called the cag pathogenicity island, where multiple genes are found that influence interactions between the bacterium and the host cell. However, by analyzing the two strains with an H. pylori gene microarray, Israel and colleagues find that the relatively benign strain, G1.1, carries a large deletion that removes 18 genes from this element. The authors focus on one gene, cagE, and show that disruption of this single gene in a B128 background yields a strain whose effects in culture and in vivo mimic those of G1.1. For more on the uses and challenges of genomic analysis of pathogenic bacteria, see the Perspective by Kato-Maeda et al. (in this issue, p.533) and other articles in our ongoing series on bacterial polymorphisms.

Witnessing clonal deletion in action

(See article on pages 555– 564.)

Clonal deletion of self-reactive T cells within the thymus represents an important protection from autoimmune disease. Unfortunately, this mechanism depends on the availability of self-antigens in the thymus, so it would seem to be of limited use for developing tolerance to peripherally expressed proteins, and indeed, many disease-related autoantigens are proteins with limited distribution. However, proteins that play their normal physiological roles elsewhere may also be expressed in the thymus, where they can be presented to developing T cells by thymic dendritic cells (DCs) or macrophages. Pugliese and coworkers now report that thymic DCs themselves express and present insulin and other pancreatic proteins that are known autoantigens in type 1 diabetes. Remarkably, these self-antigen-presenting DCs can be seen in histological preparations surrounded by T cells that are undergoing apoptosis, presumably because they are specific for the self-epitope presented by the neighboring DC. One surprise from this work concerns the transcriptional regulator AIRE, which has been implicated in the expression of certain peripheral proteins by thymic epithelial cells. Pugliese et al. find AIRE expressed in other cells in the thymus but not in self-antigen-presenting DCs, suggesting that the this organ uses several cell types and mechanisms to express these proteins and thus to promote tolerance to potentially dangerous autoantigens.

Version history
  • Version 1 (March 1, 2001): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article (0)

Go to

  • Top
  • ER stress in inflammatory bowel disease
  • Genomic analysis of pathogenic and benign gastritis bacteria
  • Witnessing clonal deletion in action
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts